Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leyi Shen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Immunopharmacology|April 6, 2025
Loss of macrophage fibroblast growth factor 12 attenuates cardiac fibrosis in pressure-overloaded myocardiumSantie Li, Mei Xue, Junjie Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase InhibitorsMichael E Stokes, Veronica Calvo, Sho Fujisawa, et al.
Journal for Immunotherapy of Cancer|May 2, 2018
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054Yiwen Li, Carmine Carpenito, George Wang, et al.
Journal for Immunotherapy of Cancer|June 6, 2018
Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054Yiwen Li, Carmine Carpenito, George Wang, et al.
Molecular Cancer Therapeutics|April 4, 2020
Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor ImmunityHelen Kotanides, Rose Marie Sattler, Maria B Lebron, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Immunopharmacology|April 6, 2025
Loss of macrophage fibroblast growth factor 12 attenuates cardiac fibrosis in pressure-overloaded myocardiumSantie Li, Mei Xue, Junjie Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase InhibitorsMichael E Stokes, Veronica Calvo, Sho Fujisawa, et al.
Journal for Immunotherapy of Cancer|May 2, 2018
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054Yiwen Li, Carmine Carpenito, George Wang, et al.
Journal for Immunotherapy of Cancer|June 6, 2018
Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054Yiwen Li, Carmine Carpenito, George Wang, et al.
Molecular Cancer Therapeutics|April 4, 2020
Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor ImmunityHelen Kotanides, Rose Marie Sattler, Maria B Lebron, et al.
Pageof 2